RIAD, Abanoub, Andrea POKORNÁ, Jitka KLUGAROVÁ, Natália ANTALOVÁ, Lucia KANTOROVÁ, Michal KOŠČÍK a Miloslav KLUGAR. Side Effects of mRNA-Based COVID-19 Vaccines among Young Adults (18–30 Years Old): An Independent Post-Marketing Study. Pharmaceuticals. Basel: MDPI, roč. 14, č. 10, s. 1-16. ISSN 1424-8247. doi:10.3390/ph14101049. 2021.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Side Effects of mRNA-Based COVID-19 Vaccines among Young Adults (18–30 Years Old): An Independent Post-Marketing Study
Autoři RIAD, Abanoub (818 Egypt, garant, domácí), Andrea POKORNÁ (203 Česká republika, domácí), Jitka KLUGAROVÁ (203 Česká republika, domácí), Natália ANTALOVÁ (703 Slovensko, domácí), Lucia KANTOROVÁ (703 Slovensko, domácí), Michal KOŠČÍK (203 Česká republika, domácí) a Miloslav KLUGAR (203 Česká republika, domácí).
Vydání Pharmaceuticals, Basel, MDPI, 2021, 1424-8247.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30104 Pharmacology and pharmacy
Stát vydavatele Švýcarsko
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 5.215
Kód RIV RIV/00216224:14110/21:00122615
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.3390/ph14101049
UT WoS 000715120800001
Klíčová slova anglicky BNT162 vaccine; COVID-19; Czech Republic; drug-related side effects and adverse reactions; mass vaccination; mRNA-1273 vaccine; phase IV; prevalence; young adult
Štítky 14110525, 14110611, 14119612, 14119613, rivok
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Mgr. Tereza Miškechová, učo 341652. Změněno: 7. 12. 2021 13:12.
Anotace
Young adults had been widely perceived as a low-risk group for COVID-19 severity; therefore, they were deprioritised within the mass vaccination strategies as their prognosis of COVID-19 infection is relatively more favourable than older age groups. On the other hand, vaccination of this demographic group is indispensable to achieve herd immunity. A cross-sectional survey-based study was used to evaluate the side effects of mRNA-based COVID-19 vaccines among university students in the Czech Republic. The validated questionnaire was delivered in a digital form, and it consisted of demographic data; COVID-19 vaccine-related anamnesis; and local, systemic, orofacial, and skin-related side effects’ prevalence, onset, and duration. Out of the 539 included participants, 70.1% were females and 45.8% were <23 years old. The vast majority (95.2%) reported at least one side effect. The most common side effect was injection site pain (91.8%), followed by fatigue (62.5%), headache (36.4%), and muscle pain (34.9%). The majority of local side effects occurred after both doses (74.4%), while most systemic side effects occurred after the second dose only (56.2%). Most local (94.2%) and systemic (93.3%) side effects resolved within three days after vaccination. Females participants’ adjusted odds ratio (AOR) showed they were 2.566 (CI 95%: 1.103–5.970) times more likely to experience post-vaccination side effects, and the participants who received two doses reported an increased AOR of 1.896 (0.708–5.077) for experiencing side effects. The results of this study imply that mRNA-based COVID-19 vaccines are highly probably safe for young adults, and further studies are required to investigate the role of medical anamnesis, prior COVID-19 infection, and gender in side effects incidence.
Návaznosti
LTC20031, projekt VaVNázev: Towards an International Network for Evidence-based Research in Clinical Health Research in the Czech Republic
Investor: Ministerstvo školství, mládeže a tělovýchovy ČR, Towards an International Network for Evidence-based Research in Clinical Health Research in the Czech Republic, INTER-COST
MUNI/A/1608/2020, interní kód MUNázev: Prohlubování znalostí v oblasti zdravotních rizik a benefitů výživy, prostředí a životního stylu III
Investor: Masarykova univerzita, Prohlubování znalostí v oblasti zdravotních rizik a benefitů výživy, prostředí a životního stylu III
MUNI/IGA/1068/2020, interní kód MUNázev: Methodological and practical aspects of the development of guidelines and rapid guidelines in public health (Akronym: RAPguidelines-public-health)
Investor: Masarykova univerzita, Methodological and practical aspects of the development of guidelines and rapid guidelines in public health
MUNI/IGA/1543/2020, interní kód MUNázev: Evidence-based Practice of Healthcare Professionals and Students in the Czech Republic (Akronym: Evidence-Based Practice in Czechia)
Investor: Masarykova univerzita, Evidence-based Practice of Healthcare Professionals and Students in the Czech Republic
VytisknoutZobrazeno: 19. 4. 2024 01:56